Pfizer

ICICI Securities is bullish on Pfizer has recommended buy rating on the stock with a target price of Rs 6100 in its research report dated November 14, 2025.

Stocks to Watch Today: Tata Steel, GNFC, Data Patterns, Nazara Tech, Prestige Estates, Lloyds Metals, Cosmo First, Entero Healthcare in focus on 13 November

Stocks to Watch, 13 November: Stocks like Tata Steel, Lloyds Metals and Energy, Prestige Estates Projects, Nazara Technologies, Indian Railway Catering and Tourism Corporation IRCTC, Entero Healthcare Solutions, Endurance Technologies, Ircon International, Cohance Lifesciences, and Data Patterns will be in focus on November 13.

Why Pfizer struck a drug-pricing deal with the Trump administration

Tariffs, political pressure and personal ties shaped a high-stakes agreement.

Trump unveils 'TrumpRx' website for cheaper drugs, Pfizer promises up to 50% discounts | Explained

According to a 2024 report by the US Health and Human Services Department, Americans often pay three times more for medicines compared to people in other developed countries.

Q1 results impact: Pfizer shares rise 5%; Black Box hits 5% lower circuit, Laxmi India Finance down 2.5%

Newly-listed shares of Laxmi India Finance fell nearly 3% on August 14 after the NBFC posted 33% sequential decline in net profit at Rs 10 crore for the quarter ended June 30, 2025

Stocks to Watch Today: Infosys, JSW Cement, All Time Plastics, IRCTC, Pfizer, Vishal Mega Mart, Muthoot Finance, Jain Irrigation, Zydus Life in focus on 14 August

Stocks to Watch, 14 August: Stocks like JSW Cement, All Time Plastics, IRCTC, Pfizer, Vishal Mega Mart, Muthoot Finance, Jain Irrigation Systems, Zydus Lifesciences, Jubilant Foodworks, United Spirits, and Man Infraconstruction will be in focus on August 14.

Stocks to Watch Today: Avenue Supermarts, Indogulf Cropsciences, Punjab National Bank, Nykaa, Aurobindo Pharma, Le Lavoir in focus on 3 July

Stocks to Watch, 3 July: Stocks like Avenue Supermarts,Hindustan Zinc, FSN E-Commerce Ventures Nykaa, Punjab National Bank, Aurobindo Pharma, Le Lavoir, Motilal Oswal Financial Services, Nestle India, Max Financial Services, and Indogulf Cropsciences will be in focus on July 3.

Trade Spotlight: How should you trade Grindwell Norton, Morepen Labs, Astral, Aditya Birla Capital, Pfizer, Clean Science and others on May 23?

Consolidation is likely to continue, with the indices attempting to defend the previous Thursday’s low in the upcoming session. Below are some short-term trading ideas to consider.

Pfizer shares jump 11% as profit soars 85% YoY in Q4FY25

Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit for the March quarter of FY25

Pfizer abandons obesity pill after liver injury in major setback

The news will intensify pressure on Pfizer Chief Executive Officer Albert Bourla, who has repeatedly pointed to the drugmaker’s pipeline as an undervalued source of future growth.

Pfizer shares rise by 7% after marketing and sale pact with Mylan for two neuro therapy brands

The marketing and supply agreement is for a period of five years for India only, to enhance distribution and in clinic presence of the two products.

Stock Radar: Bharti Airtel, Adani Power, Suzlon, Federal Bank, Quess Corp, Genesys International in focus on Tuesday

Stocks like JSW Infrastructure, Tata Technologies, Spandana Sphoorty Financial, Kalpataru Projects International, Indraprastha Gas, Restaurant Brands Asia, Ajanta Pharma, Pfizer, and Tamilnad Mercantile Bank will also be in focus on October 29.

Pfizer wins bid to invalidate GSK's patents over RSV vaccine

The two pharmaceutical giants are among a number of companies in competition for a vaccine for RSV, which typically causes cold-like symptoms but is also a leading cause of pneumonia in toddlers and older adults.

World Street | Open AI's valuation soars to $150 bln, Pfizer's stake sale in Haleon, Yen weakens and more

From Tesla's persisting problems to Formula One and LVMH's latest 10-year long tie-up, here's a look at some of the major developments from across the world.

World Street | Powell hints at smaller cuts ahead, Aston Martin's profit warning, PepsiCo's new venture and more

From US drugmaker Pfizer's stake sale in Sensodyne maker Haleon to Beijing joining the list of Chinese cities easing home-buying restrictions, here's a look at some of the major developments from across the world.

Nvidia, Pfizer lead $80 million funding for Israeli medical AI tech firm CytoReason

Nvidia, Pfizer, Thermo Fisher and venture capital investor OurCrowd participated in the round, CytoReason said

Pfizer moves forward with once-daily weight loss pill

The Pfizer drug is part of the second-generation of weight loss pills, under development by companies including Eli Lilly and Novo Nordisk, that will offer patients more convenient dosing instead of injections

World Street | Nvidia's stellar earnings, Pfizer's cost-cut plans, Target's weak guidance and more

From a brewing price war in China's AI chat bot space to Nvidia delivering strong quarterly results, here's a look at some of the major developments from across the world.

Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit

Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market.